nih-gov/www.grants.nih.gov/grants/guide/notice-files/NOT-OD-02-029.html

234 lines
No EOL
11 KiB
HTML

<!-- Changed ON 09/24/2024 -->
<!-- Google Tag Manager -->
<script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
})(window,document,'script','dataLayer','GTM-T2DH393N');</script>
<!-- End Google Tag Manager -->
<HTML lang="en-US">
<HEAD>
<!-- From DocTemplateOld.txt -->
<TITLE>NOT-OD-02-029: NOTICE OF LEGISLATIVE MANDATES CONTAINED IN THE FY2002 OMNIBUS APPROPRIATIONS P.L. 107-116; SIGNED JANUARY 10, 2002</TITLE>
<META NAME="description" CONTENT="NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: NOTICE OF LEGISLATIVE MANDATES CONTAINED IN THE FY2002 OMNIBUS APPROPRIATIONS P.L. 107-116; SIGNED JANUARY 10, 2002 NOT-OD-02-029. NIH">
<META NAME="Keywords" CONTENT="NOT-OD-02-029: NOTICE OF LEGISLATIVE MANDATES CONTAINED IN THE FY2002 OMNIBUS APPROPRIATIONS P.L. 107-116; SIGNED JANUARY 10, 2002">
</HEAD>
<BODY BGCOLOR="#FFFFFF" TEXT="#000000">
<pre>
NOTICE OF LEGISLATIVE MANDATES CONTAINED IN THE FY2002 OMNIBUS APPROPRIATIONS
P.L. 107-116; SIGNED JANUARY 10, 2002
Release Date: January 25, 2002
NOTICE: NOT-OD-02-029
National Institutes of Health
The purpose of this Notice is to provide information on the following
statutory provisions that limit the use of funds on National Institutes
of Health (NIH) grant, cooperative agreement, and contract awards:
(1) Acknowledgement of Federal Funding (Section 507)
(2) Anti-Lobbying (Section 503)
(3) Continued Salary Limitation (Section 204)
(4) Ban on Funding of Human Embryo Research (Section 510)
(5) Purchase of American-Made Equipment and Products (Section 506)
(6) Limitation on Use of Funds for Promotion of Legalization of
Controlled Substances (Section 511)
(7) Restriction on Distribution of Sterile Needles (Section 505)
(1) ACKNOWLEDGEMENT OF FEDERAL FUNDING (Section 507)
When issuing statements, press releases, requests for proposals, bid
solicitations and other documents describing projects or programs
funded in whole or in part with Federal money, all grantees receiving
Federal funds included in this Act, including but not limited to State
and local governments and recipients of Federal research grants, shall
clearly state: (1) the percentage of the total costs of the program or
project which will be financed with Federal money; (2) the dollar
amount of Federal funds for the project or program; and (3) percentage
and dollar amount of the total costs of the project or program that
will be financed by non-governmental sources.
(2) ANTI-LOBBYING (Section 503)
No part of any appropriation contained in this Act shall be used, other
than for normal and recognized executive-legislative relationships, for
publicity or propaganda purposes, for the preparation, distribution, or
use of any kit, pamphlet, booklet, publication, radio, television, or
video presentation designed to support or defeat legislation pending
before the Congress or any State legislature, except in presentation to
the Congress or any State legislature itself. In addition, no part of
any appropriation contained in this Act shall be used to pay the salary
or expenses of any grant or contract recipient, or agent acting for
such recipient, related to any activity designed to influence
legislation or appropriations pending before the Congress or any
State legislature.
(3) CONTINUED SALARY LIMITATION (Section 204)
None of the funds appropriated in this Act for the National Institutes
of Health, the Agency for Healthcare Research and Quality, and the
Substance Abuse and Mental Health Services Administration shall be used
to pay the salary of an individual, through a grant or other extramural
mechanism, at a rate in excess of Executive Level I of the Federal
Executive Pay Scale. The level effective October 1, 2001 through
December 31, 2001 is $161,200. Effective January 1, 2002, this amount
increases to $166,700. Applications and proposals with categorical
direct cost budgets reflecting direct salaries for individuals in
excess of Executive Level I per year will be adjusted in accordance
with the legislative salary limitation. Please refer to NIH GUIDE
NOTICE, NOT-OD-02-030:
<a href="http://grants.nih.gov/grants/guide/notice-files/NOT-OD-02-030.html">http://grants.nih.gov/grants/guide/notice-files/NOT-OD-02-030.html</a> dated
January 25, 2002 for additional information.
(4) BAN ON FUNDING OF HUMAN EMBRYO RESEARCH (Section 510)
This section continues the current ban that prohibits NIH from using
appropriated funds to support human embryo research. Grant,
cooperative agreement and contract funds may not be used for (1) the
creation of a human embryo or embryos for research purposes; or (2)
research in which a human embryo or embryos are destroyed, discarded,
or knowingly subjected to risk of injury or death greater than that
allowed for research on fetuses in utero under 45 CFR 46.208(a)(2) and
section 498(b) of the Public Health Service Act (42 U.S.C. 289g(b)).
For purposes of this section, the term ``human embryo"
or "embryos'' includes any organism not protected as a human subject
under 45 CFR 46 as of the date of the enactment of this Act, that is
derived by fertilization, parthenogenesis, cloning, or any other means
from one or more human gametes or human diploid cells.
The NIH has published final guidelines on stem cell research that
relate to this topic. The URL is
<a href="http://stemcells.nih.gov/index.asp">http://stemcells.nih.gov/index.asp</a>.
(5) PURCHASE OF AMERICAN-MADE EQUIPMENT AND PRODUCTS (Section 506)
It is the sense of the Congress that, to the greatest extent
practicable, all equipment and products purchased with funds made
available in this Act should be American-made. In providing financial
assistance to, or entering into any contract with, any entity using
funds made available in this Act, the head of each Federal agency, to
the greatest extent practicable, shall provide to such entity a notice
describing this requirement. If it has been finally determined by a
court or Federal agency that any person intentionally affixed
a label bearing a ``Made in America'' inscription, or any inscription
with the same meaning, to any product sold in or shipped to the United
States that is not made in the United States, the person shall be
ineligible to receive any contract or subcontract made with funds made
available in this Act, pursuant to the debarment, suspension, and
ineligibility procedures described in sections 9.400 through 9.409 of
title 48, Code of Federal Regulations.
(6) LIMITATION ON USE OF FUNDS FOR PROMOTION OF LEGALIZATION OF
CONTROLLED SUBSTANCES (Section 511)
None of the funds made available in this Act may be used for any
activity that promotes the legalization of any drug or other substance
included in schedule I of the schedules of controlled substances
established by section 202 of the Controlled Substances Act (21 U.S.C.
812). The limitation above shall not apply when there is significant
medical evidence of a therapeutic advantage to the use of such drug or
other substance or that federally sponsored clinical trials are being
conducted to determine therapeutic advantage.
(7) RESTRICTION ON DISTRIBUTION OF STERILE NEEDLES (Section 505)
Notwithstanding any other provision of this Act, no funds appropriated
under this Act shall be used to carry out any program of distributing
sterile needles or syringes for the hypodermic injection of any
illegal drug.
INQUIRIES
For more information concerning policies relating to grants, please
visit <a href="http://grants.nih.gov/grants/policy/policy.htm">http://grants.nih.gov/grants/policy/policy.htm</a>. For information
on contract policy, please visit
<a href="http://ocm.od.nih.gov/contracts/contract.htm">http://ocm.od.nih.gov/contracts/contract.htm</a>. If additional questions
remain, please contact your awarding grants or contracts management
office in the NIH Institutes and Centers.
</pre>
<P><HR><P>
<A HREF="/grants/guide/WeeklyIndex.cfm?WeekEnding=01-25-02">Weekly TOC for this Announcement</A><br>
<A HREF="/grants/guide/index.html">NIH Funding Opportunities and Notices</A>
<!-- Start DHHSFooter.cfm 3/13/2008-->
<br><br>
<hr>
<table align="center">
<tr><td align="center" colspan="6"><span class='st_facebook_hcount' displayText='Facebook'></span>
<span class='st_twitter_hcount' displayText='Tweet'></span>
<span class='st_linkedin_hcount' displayText='LinkedIn'></span>
<span class='st_email_hcount' displayText='Email'></span>
<span class='st_sharethis_hcount' displayText='ShareThis'></span><br></td></tr>
<tr>
<td>
<div align="center"><a href="/grants/oer.htm"><img src="/images7/nih-oer-logo.jpg" alt="NIH Office of Extramural Research Logo" usemap="#Map2" border="0"></a></div>
<map name="Map2" id="Map2">
<area shape="rect" coords="89,17,359,39" href="http://www.nih.gov" />
<area shape="rect" coords="91,39,286,58" href="http://grants.nih.gov/grants/oer.htm" />
<area shape="rect" coords="3,5,78,55" href="http://grants.nih.gov/grants/oer.htm" />
</map>
</td>
<td width="20">&nbsp;</td>
<td>
<a href="https://www.hhs.gov/"><img src="/images7/dhhs_sm.gif" width="36" height="37" border="0" alt="Department of Health and Human Services (HHS) - Home Page" long desc="Logo, circular in shape, depicting an American eagle in-flight with stylized profiles of human faces appearing on the trailing edge of the wings. The perimeter of the logo is encircled with the words 'Department of Health and Human Services U S A'"></a>
</td>
<td valign="middle">
<font size="-1" face="Arial">Department of Health<br>and Human Services (HHS)</font>
</td>
<td width="20">&nbsp;</td>
<td>
<a href="https://www.usa.gov/"><img src="/images7/USA_Gov_logo.gif" border="0" alt="USA.gov - Government Made Easy" long desc="Logo,- the words 'USA.gov - Government Made Easy' with single streaking star above the logo"></a>
</td>
</tr>
<tr align="center">
<td colspan="7">
</td>
</tr>
<tr align="center">
<td colspan="7">
<span style="color:#6E6E6E; font-size:1.0em; font-family: 'Trebuchet MS', Arial, Helvetica, sans-serif">NIH... Turning Discovery Into Health<sup>&reg;</sup></span><br><br>
</td>
</tr>
</table>
<!-- End DHHSFooter.cfm 3/13/2008-->
</BODY>
</HTML>